The nurse taking a focused health history for a patient with possible testicular cancer will ask the patient about a history of
a. testicular torsion.
b. testicular trauma.
c. undescended testicles.
d. sexually transmitted infection (STI).
ANS: C
Cryptorchidism is a risk factor for testicular cancer if it is not corrected before puberty. STI, testicular torsion, and testicular trauma are risk factors for other testicular conditions but not for testicular cancer.
You might also like to view...
Which nursing action is designed to avoid unnecessary heat loss in the newborn?
a. Place a blanket over the scale before weighing the infant. b. Maintain room temperature at 70° F. c. Undress the infant completely for assessments so they can be finished quickly. d. Take the rectal temperature every hour to detect early changes.
While speaking with a patient who is experiencing depression, which of the following strategies might be most helpful?
a. speaking very loudly since they are certainly hard of hearing b. recording important information for them in a notebook to refer to later c. ignoring the person and discussing their condition with a family member d. telling them that their depression will go away on its own if they think positively
A nurse is discussing the symptomology of osteoarthritis (OA) with a client. The nurse shows an understanding of the disease process when identifying which of the following as an initial symptom of the disease?
1. Painful stiffness in the joints of the fingers 2. Popping sensation felt in the wrist joint when typing 3. Knee pain when leg is at rest 4. A fine red rash on the elbow that is constant
The Pure Food and Drug Act (PFDA) of 1906 was significant in that it gave the government the power to prohibit drug labels from claiming false therapeutic benefits
However, there were still several weaknesses in the legislature of this act. Which statements most accurately describe these weaknesses? 1. This law did not require drug manufacturers to prove that the drug was effective in its claims. 2. This law did not prevent drugs from being marketed for any disease. 3. This law required all drug labels to accurately describe their contents. 4. This law required adequate testing for safety prior to marketing. 5. This law did not encourage the development of drugs for rare or unusual disorders.